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Structural changes during DNA binding by the 
I-SmaMI meganuclease. An alpha helix in the 
extreme C-terminus (Helix 11) of the enzyme is 
positioned away from the rest of the structure 
in the unbound and hypothetical non-
productive binding form. The N-terminal 
domain of the enzyme contacts the DNA 
before the C-terminal domain makes close 
contacts (seen in the middle hypothetical non-
productive binding complex). Finally, helix 11 
rotates to contact the DNA in the final 
productive binding form of the enzyme. 
Changes in the structure of the DNA are also 
apparent upon binding. 
 
Image provided by Betty Shen. 
 
 
As research on gene editing technology is rapidly expanding, the need for investigation into how 
specificity and delivery of gene-editing agents can be achieved is becoming more acute.  The 
LAGLIDADG meganucleases are highly specific DNA cleaving enzymes that are relatively small and 
create 3' overhangs in the DNA, which is desirable for homology-driven repair of double-strand 
breaks (i.e. gene editing).  In nature, LAGLIDADG meganucleases are found as either homodimers 
or pseudosymmetric single-polypeptide monomers, forming either two identical or pseudosymmetric 
domains, which together contact 20-22 base-pairs of DNA.  While the homodimeric nucleases 
recognize palindromic DNA sequence motifs, the monomeric enzymes target and cleave fully 
asymmetric sequence motifs, allowing for a wider range of target specificity.  The two 
pseudosymmetric domains make distinct contributions to DNA binding and cleavage activity and this 
has made re-engineering of these enzymes challenging.  A detailed view of the structure of an 
enzyme in different stages of catalysis may reveal crucial information that would aid efforts toward its 
re-design for gene editing purposes.  
February 14, 2016 SCIENCE SPOTLIGHT 
 
2 Volume 6, Issue 2 | Fred Hutchinson Cancer Research Center 
 
High resolution structural and biochemical information on one of these monomeric pseudosymmetric 
meganucleases, called I-SmaMI, was gathered and recently published in the Journal of Molecular 
Biology, following a fruitful collaboration between Fred Hutch investigators in Barry Stoddard’s Lab 
(Basic Sciences Division) and scientists in Brett Kaiser’s Lab at Seattle University.  Staff scientist 
Betty Shen (Stoddard Lab) determined the structure of I-SmaMI by X-ray crystallography in three 
different states: unbound (no DNA), bound to DNA, and bound to cleaved DNA (see Figure, high-
resolution here).  She observed that the enzyme undergoes significant structural changes between 
the free and DNA-bound state; a C-terminal helix goes through a rigid-body rotation toward the DNA 
and subtle but significant conformational changes occur in the left and right domains of the 
enzyme.  Given the obvious change in the position of the C-terminal helix between unbound and 
bound states, the scientists wanted to test the contribution of this feature to catalysis.  They purified 
a mutant of I-SmaMI lacking the helix (Δhelix11) and found that this mutant had significantly reduced 
ability to bind as well as cleave DNA.  These results suggest that this helix is required for full 
enzymatic activity.  Next, the authors wanted to further interrogate the contribution of each domain to 
DNA-binding.  Under the direction of Brett Kaiser, formerly a postdoc and staff scientist at Fred 
Hutch (Strong Lab, Stoddard Lab), a student at Seattle University uncovered important biochemical 
properties of the enzyme.   
They created strands of DNA containing the I-SmaMI target sequence but mutated either the "left" or 
"right" DNA target sequence (called "half sites"), which bind the N- or C- terminal domain of the 
enzyme, respectively.  They found that mutating the right half-site did not severely compromise 
binding but mutating the left DNA half-site completely abolished binding.  These results suggest that 
the N-terminal domain contributes the majority of the DNA-binding affinity of the enzyme just prior to 
the formation of the transition state that precedes full binding and cleavage.  Turning to mutagenesis 
of the protein itself, the authors investigated the contribution of the catalytic residues in each domain 
to cleavage activity.  They found that disrupting the N-terminal domain catalytic residues abrogated 
cleavage activity more than perturbing the catalytic site of the C-terminal domain.  They hypothesize 
that the binding of a "number of arginine and lysine residues at the surface of the N-terminal domain 
may be responsible for the recognition and anchoring of I-SmaMI to a specific patch of DNA bases 
preceding the 'central four' bases which in turn, triggers the conversion between the "non-productive" 
and "productive" complexes," said Betty Shen.  Investigations are currently underway to investigate 
this implication.   
This research has illuminated the asymmetric contribution of the N-terminal domain of monomeric 
LAGLIDADG meganucleases to DNA binding and cleavage and also the importance of the final C-
terminal helix for function.  This is valuable information not only for those interested in engineering 
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enzymes for gene editing but also for advancing our understanding of protein-DNA interactions in 
general.   
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